Article Versions Notes

Gill J, Stella D, Dogliotti I, Dellacasa C, Giaccone L, Busca A. Use of Letermovir for CMV Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: Review of the Literature and Single-Center Real-Life Experience. Hemato. 2023; 4(2):158-169. https://doi.org/10.3390/hemato4020013

Gill, Jessica, Davide Stella, Irene Dogliotti, Chiara Dellacasa, Luisa Giaccone, and Alessandro Busca. 2023. "Use of Letermovir for CMV Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: Review of the Literature and Single-Center Real-Life Experience" Hemato 4, no. 2: 158-169. https://doi.org/10.3390/hemato4020013

Gill, J., Stella, D., Dogliotti, I., Dellacasa, C., Giaccone, L., & Busca, A. (2023). Use of Letermovir for CMV Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: Review of the Literature and Single-Center Real-Life Experience. Hemato, 4(2), 158-169. https://doi.org/10.3390/hemato4020013